Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleImaging

Study of Attenuation Correction Using a Cardiac Dynamic Phantom: Synchronized Time-Phase–Gated Attenuation Correction Method

Narihiro Hara, Masahisa Onoguchi, Hiroyuki Kawaguchi, Noriko Matsushima, Osamu Houjou, Masakazu Murai, Kohei Nakano and Wakana Makino
Journal of Nuclear Medicine Technology April 2024, jnmt.123.266785; DOI: https://doi.org/10.2967/jnmt.123.266785
Narihiro Hara
1Radiological Technology, Sumitomo Hospital, Osaka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masahisa Onoguchi
2Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroyuki Kawaguchi
1Radiological Technology, Sumitomo Hospital, Osaka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noriko Matsushima
1Radiological Technology, Sumitomo Hospital, Osaka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Osamu Houjou
1Radiological Technology, Sumitomo Hospital, Osaka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masakazu Murai
1Radiological Technology, Sumitomo Hospital, Osaka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kohei Nakano
1Radiological Technology, Sumitomo Hospital, Osaka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wakana Makino
3Department of Cardiology, Sumitomo Hospital, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Outline of ECG-synchronized dynamic cardiac phantom.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Attenuation correction region based on ECG waveform of STPG SPECT: STPGAC ECG (A); UnTagAC ECG (B); 75% GAC ECG (C); 40% GAC ECG (D).

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Attenuation correction region based on ECG waveform of NPG SPECT: UnTagAC ECG (A); 75% GAC ECG (B); 40% GAC ECG (C).

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Difference in perfusion between normal and defect regions in heart rate variability of 360° acquisition: UnTagAC ECG (A); 75% GAC ECG (B); 40% GAC ECG (C).

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Difference in perfusion between normal and defect regions in heart rate variability of 180° acquisition: UnTagAC ECG (A); 75% GAC ECG (B); 40% GAC ECG (C).

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    Difference in perfusion between normal and defect regions in myocardial wall variation: UnTagAC ECG (A); 75% GAC ECG (B); 40% GAC ECG (C).

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1.

    Cardiac Function Analysis of Heart Rate Variability (360°)

    ParameterTheoretic phantom values (mL)CTSTPG SPECTNPG SPECT
    STPGACUnTagAC75% GAC40% GACUnTagAC75% GAC40% GACNon-AC
    40 bpm
     ED (mL)140.4128.1128.0127.0127.0129.0130.0129.0131.0130.0
     ES (mL)119.9112.0112.0107.0108.0109.0112.0111.0113.0112.0
     LVEF (%)14.612.612.515.715.015.513.814.013.713.8
    50 bpm
     ED (mL)140.4129.5130.0128.0129.0130.0131.0131.0133.0131.0
     ES (mL)119.9114.6115.0111.0112.0112.0114.0114.0117.0115.0
     LVEF (%)14.611.511.513.313.213.813.013.012.012.2
    60 bpm
     ED (mL)140.4128.8128.0124.0125.0127.0127.0127.0129.0127.0
     ES (mL)119.9111.6111.0105.0106.0108.0108.0110.0111.0111.0
     LVEF (%)14.613.413.315.315.215.015.013.414.012.6
    70 bpm
     ED (mL)140.4132.6133.0128.0129.0130.0132.0133.0133.0131.0
     ES (mL)119.9115.7116.0108.0109.0111.0112.0113.0114.0113.0
     LVEF (%)14.612.712.815.615.514.615.215.014.313.7
    80 bpm
     ED (mL)140.4133.2133.0129.0130.0131.0131.0133.0135.0133.0
     ES (mL)119.9116.8116.0111.0112.0113.0113.0115.0117.0116.0
     LVEF (%)14.612.312.814.013.813.713.713.513.312.8
    90 bpm
     ED (mL)140.4131.9132.0127.0129.0130.0132.0132.0134.0130.0
     ES (mL)119.9114.9115.0108.0110.0110.0113.0113.0115.0111.0
     LVEF (%)14.612.912.915.014.715.414.414.414.214.6
    100 bpm
     ED (mL)140.4131.4131.0128.0129.0129.0131.0131.0134.0130.0
     ES (mL)119.9115.5115.0110.0111.0112.0114.0113.0117.0113.0
     LVEF (%)14.612.112.214.114.013.213.013.712.713.1
    • Non-AC = non—attenuation-corrected.

    • View popup
    TABLE 2.

    Cardiac Function Analysis of Heart Rate Variability (180°)

    ParameterTheoretic phantom values (mL)CTSTPG SPECTNPG SPECT
    STPGACUnTagAC75% GAC40% GACUnTagAC75% GAC40% GACNon-AC
    40 bpm
     ED (mL)140.4128.1132.0127.0130.0128.0132.0132.0133.0136.0
     ES (mL)119.9112.0116.0110.0114.0111.0115.0116.0117.0116.0
     LVEF (%)14.612.612.113.412.313.312.912.112.014.7
    50 bpm
     ED (mL)140.4129.5134.0130.0131.0132.0135.0136.0137.0135.0
     ES (mL)119.9114.6117.0110.0112.0113.0116.0118.0118.0111.0
     LVEF (%)14.611.512.715.414.514.414.113.213.917.8
    60 bpm
     ED (mL)140.4128.8135.0130.0132.0132.0135.0136.0137.0140.0
     ES (mL)119.9111.6118.0110.0112.0112.0116.0118.0119.0114.0
     LVEF (%)14.613.412.615.415.215.214.113.213.118.6
    70 bpm
     ED (mL)140.4132.6134.0129.0129.0131.0133.0134.0135.0139.0
     ES (mL)119.9115.7116.0109.0110.0111.0115.0116.0116.0115.0
     LVEF (%)14.612.713.415.514.715.313.513.414.117.3
    80 bpm
     ED (mL)140.4133.2134.0130.0129.0131.0135.0136.0136.0136.0
     ES (mL)119.9116.8118.0112.0112.0114.0118.0118.0119.0112.0
     LVEF (%)14.612.311.913.813.213.012.613.212.517.6
    90 bpm
     ED (mL)140.4131.9133.0127.0128.0130.0133.0139.0136.0134.0
     ES (mL)119.9114.9119.0112.0113.0114.0113.0125.0121.0111.0
     LVEF (%)14.612.910.511.811.712.315.010.111.017.2
    100 bpm
     ED (mL)140.4131.4133.0127.0128.0129.0133.0133.0135.0132.0
     ES (mL)119.9115.5117.0109.0110.0113.0115.0116.0118.0110.0
     LVEF (%)14.612.112.014.214.112.413.512.812.616.7
    • Non-AC = non—attenuation-corrected.

    • View popup
    TABLE 3.

    Results of Polar Map Segment Analysis and Correlation Coefficient for 360° Acquisitions in Heart Rate Variability

    PerfusionSTPG SPECTNPG SPECT
    UnTagAC75% GAC40% GACUnTagAC75% GAC40% GACNon-AC
    40 bpm
     Normal (P)0.4680.4920.4980.4390.4760.4740.121
     Defect (P)0.4440.3020.3390.5000.4900.5000.430
     STPGAC method vs. (r)0.9960.9970.9970.9990.9980.9990.814
    50 bpm
     Normal (P)0.4500.3860.4540.4950.4940.4780.115
     Defect (P)0.4640.4930.4680.3280.4680.4190.303
     STPGAC method vs. (r)0.9970.9640.9980.9960.9970.9980.916
    60 bpm
     Normal (P)0.4820.4920.4870.4390.4700.4650.119
     Defect (P)0.4990.4590.4510.4210.4880.4770.444
     STPGAC method vs. (r)0.9970.9960.9980.9970.9970.9960.876
    70 bpm
     Normal (P)0.4610.4750.4420.4610.4450.4890.105
     Defect (P)0.4570.4660.4980.4160.4160.4260.340
     STPGAC method vs. (r)0.9830.9760.9750.9860.9710.9780.882
    80 bpm
     Normal (P)0.4800.4930.4660.4930.4910.4290.116
     Defect (P)0.4650.4940.4340.4620.4340.4000.388
     STPGAC method vs. (r)0.9980.9980.9960.9970.9960.9930.887
    90 bpm
     Normal (P)0.4670.4460.4950.4210.4240.4460.128
     Defect (P)0.4650.5000.5000.4240.4650.4670.479
     STPGAC method vs. (r)0.9960.9950.9970.9960.9950.9930.912
    100 bpm
     Normal (P)0.4160.4320.4690.4750.4540.4560.109
     Defect (P)0.4640.4300.4980.4620.4300.3860.470
     STPGAC method vs. (r)0.9940.9920.9960.9980.9940.9970.902
    • Non-AC = non—attenuation-corrected; r = correlation coefficient.

    • Normal = F(10,10) < 0.5, P = 0.05; defect = F(5,5) < 0.5, P = 0.05.

    • View popup
    TABLE 4.

    Results of Polar Map Segment Analysis and Correlation Coefficient for 180° Acquisitions in Heart Rate Variability

    PerfusionSTPG SPECTNPG SPECT
    UnTagAC75% GAC40% GACUnTagAC75% GAC40% GACNon-AC
    40 bpm
     Normal (P)0.4820.4930.4480.4830.4520.4480.087
     Defect (P)0.2460.4670.3880.2700.4550.3880.402
     STPGAC method vs. (r)0.9630.9990.9950.9870.9960.9950.884
    50 bpm
     Normal (P)0.2820.4090.3590.2820.4090.3590.110
     Defect (P)0.2830.4540.3900.2830.4540.3900.429
     STPGAC method vs. (r)0.9820.9950.9970.9820.9950.9970.920
    60 bpm
     Normal (P)0.5000.4680.4930.3960.4860.3760.121
     Defect (P)0.4770.4790.4600.2890.3840.2930.403
     STPGAC method vs. (r)0.9950.9960.9950.9910.9940.9960.881
    70 bpm
     Normal (P)0.4600.4180.4060.4710.4650.4760.104
     Defect (P)0.4490.4770.4560.3880.4090.3660.497
     STPGAC method vs. (r)0.9950.9840.9860.9930.9840.9920.895
    80 bpm
     Normal (P)0.4940.4770.4960.3910.4940.4250.119
     Defect (P)0.4930.4410.5000.3860.4410.3540.489
     STPGAC method vs. (r)0.9980.9890.9980.9930.9920.9960.904
    90 bpm
     Normal (P)0.4530.3960.4560.3810.4640.4350.147
     Defect (P)0.4640.2930.4970.4060.3190.3630.443
     STPGAC method vs. (r)0.9950.9610.9950.9910.9800.9950.899
    100 bpm
     Normal (P)0.3210.4480.4490.4380.4840.4570.098
     Defect (P)0.4730.4830.4750.3800.4550.4270.487
     STPGAC method vs. (r)0.9190.9910.9970.9920.9860.9920.918
    • Non-AC = non—attenuation-corrected; r = correlation coefficient.

    • Normal = F(10,10) < 0.5, P = 0.05; defect = F(5,5) < 0.5, P = 0.05.

    • View popup
    TABLE 5.

    Results of Cardiac Function Analysis of Myocardial Wall Variation

    Parameter20:2020:1020:05
    ED (mL)ES (mL)LVEF (%)ED (mL)ES (mL)LVEF (%)ED (mL)ES (mL)LVEF (%)
    Theoretical phantom values (mL)556.9216.761.1479.9216.754.8441.5216.750.9
    CT421.9186.755.7397.4192.151.7385.4193.549.8
    STPG SPECT
     STPGAC420.0187.055.5396.0191.051.8385.0194.049.6
     UnTagAC42318656.039118552.738619449.7
     75% GAC42218655.940019351.838619449.7
     40% GAC4251875640619651.738819450.0
    NPG SPECT
     UnTagAC423.0186.056.0391.0185.052.7386.0194.049.7
     75% GAC422.0186.055.9400.0193.051.8386.0194.049.7
     40% GAC425.0187.056.0406.0196.051.7388.0194.050.0
     Non-AC418.0191.054.3382.0185.051.6388.0201.048.2
    • Non-AC = non—attenuation-corrected.

    • View popup
    TABLE 6.

    Results of Polar Map Segment Analysis and Correlation Coefficient for Myocardial Wall Variation

    Gated SPECTAC20:2020:1020:05
    PSTPGAC method vs. (r)PSTPGAC method vs. (r)PSTPGAC method vs. (r)
    NormalDefectNormalDefectNormalDefect
    Perfusion (%)
     STPG SPECTUnTagAC0.4770.5000.9960.3180.4100.9870.4430.4420.993
     75% GAC0.4770.5000.9910.4610.4100.9990.4680.4420.993
     40% GAC0.4510.4300.9910.2420.4100.9810.4740.4420.995
     NPG SPECTUnTagAC0.4240.5000.9930.3470.4100.9840.4330.4420.996
     75% GAC0.4400.5000.9900.3760.3440.9850.3460.3740.991
     40% GAC0.3570.5000.9890.3660.3440.9880.3710.2950.991
     Non AC0.0560.4100.9050.0140.3440.8530.0280.4420.885
    ED (%)
     STPG SPECTUnTagAC0.4180.2950.9990.2690.5000.9920.4390.5000.996
     75% GAC0.4180.2950.9990.3550.5000.9960.1240.5000.824
     40% GAC0.4260.2950.9990.2760.5000.9930.3020.5000.976
     NPG SPECTUnTagAC0.4290.5000.9990.4950.2950.9920.4920.5000.999
     75% GAC0.4770.5000.9990.4860.4100.9990.4890.5000.999
     40% GAC0.4370.5000.9990.2920.5000.9930.4910.5000.999
     Non AC0.1580.5000.8060.0340.4300.8960.0270.5000.907
    ES (%)
     STPG SPECTUnTagAC0.4590.5000.9990.3800.5000.9890.4490.5000.997
     75% GAC0.4590.4510.9990.4020.4510.9970.4670.4580.998
     40% GAC0.4670.5000.9990.3890.5000.9920.4970.5000.997
     NPG SPECTUnTagAC0.4760.5000.9990.4150.4510.9800.4580.5000.999
     75% GAC0.4560.4510.9990.4980.4510.9990.4810.4580.999
     40% GAC0.4470.5000.9990.3970.5000.9940.4760.5000.999
     Non AC0.1460.2050.8760.0660.3300.7840.1300.5000.857
    Motion (mm)
     STPG SPECTUnTagAC0.4980.5000.9980.0000.4240.9530.0110.4720.998
     75% GAC0.4980.4600.9990.4150.4240.9970.4620.5000.999
     40% GAC0.4920.4780.9980.4190.4760.9900.4680.5000.998
     NPG SPECTUnTagAC0.4890.4790.9980.4140.4760.9910.4850.4750.998
     75% GAC0.4910.4790.9990.4830.5000.9900.4830.4750.999
     40% GAC0.4860.4790.9980.4220.4780.9940.4860.5000.998
     Non AC0.3960.3950.9860.4300.3950.9420.2980.4100.968
    Thickening (%)
     STPG SPECTUnTagAC0.3890.3740.9980.4530.4000.9940.4240.3740.989
     75% GAC0.3890.2950.9990.4970.4300.9930.4610.3740.990
     40% GAC0.4560.3740.9980.4930.5000.9950.4460.4300.986
     NPG SPECTUnTagAC0.4080.3740.9920.4620.4630.9910.4240.4300.992
     75% GAC0.4720.5000.9960.4990.4580.9980.4510.5000.994
     40% GAC0.4090.3740.9850.4920.5000.9980.4880.5000.996
     Non AC0.4240.50.8740.4360.4630.9300.4260.3300.878
    • AC = attenuation correction method; r = correlation coefficient; non-AC = non–attenuation-corrected.

    • Normal = F(10,10) < 0.5, P = 0.05; defect = F(5,5) < 0.5, P = 0.05.

Additional Files

  • Figures
  • Tables
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Appendices
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 53 (1)
Journal of Nuclear Medicine Technology
Vol. 53, Issue 1
March 1, 2025
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Study of Attenuation Correction Using a Cardiac Dynamic Phantom: Synchronized Time-Phase–Gated Attenuation Correction Method
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Study of Attenuation Correction Using a Cardiac Dynamic Phantom: Synchronized Time-Phase–Gated Attenuation Correction Method
Narihiro Hara, Masahisa Onoguchi, Hiroyuki Kawaguchi, Noriko Matsushima, Osamu Houjou, Masakazu Murai, Kohei Nakano, Wakana Makino
Journal of Nuclear Medicine Technology Apr 2024, jnmt.123.266785; DOI: 10.2967/jnmt.123.266785

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Study of Attenuation Correction Using a Cardiac Dynamic Phantom: Synchronized Time-Phase–Gated Attenuation Correction Method
Narihiro Hara, Masahisa Onoguchi, Hiroyuki Kawaguchi, Noriko Matsushima, Osamu Houjou, Masakazu Murai, Kohei Nakano, Wakana Makino
Journal of Nuclear Medicine Technology Apr 2024, jnmt.123.266785; DOI: 10.2967/jnmt.123.266785
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Early 10-Minute Postinjection [18F]F-FAPI-42 uEXPLORER Total-Body PET/CT Scanning Protocol for Staging Lung Cancer Using HYPER Iterative Reconstruction
  • Single- Versus Dual-Time-Point Imaging for Transthyretin Cardiac Amyloid Using 99mTc-Pyrophosphate
  • Software Discrepancies in Radionuclide-Derived Left Ventricular Ejection Fraction
Show more Imaging

Similar Articles

Keywords

  • SPECT/CT system
  • myocardial blood flow
  • electrocardiography-synchronized CT imaging
  • synchronized time-phase–gated SPECT
  • synchronized time-phase–gated attenuation correction electrocardiogram
SNMMI

© 2025 SNMMI

Powered by HighWire